Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Slingshot Biosciences Denmark ApS
APS
Bankrupt
CVR 43833138
Sundkrogsgade 21, 2100
København Ø
Wholesale of pharmaceutical and medical goods
· NACE 4646
Est. 2023 · 3 years old
1 employees
Monitor
Share
Denmark
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
Slingshot Biosciences Denmark ApS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Gross profit
DKK millions
0M
0M
1M
1M
1M
0M
2023
EBITDA
DKK millions
0M
-0M
-1M
-1M
-1M
-1M
2023
Income statement
DKK thousands
Item
2023
Gross profit
-45
Staff expenses
-748
EBITDA
-793
Depreciation & amort.
-0
EBIT
-793
Net financials
-1
Profit before tax
Balance sheet
DKK thousands
Item
2023
Total assets
117
Equity
-754
Long-term debt
0
Short-term debt
870
Total debt
870
Financial ratios
5-year trend
EBITDA margin (of gross profit)
-79255600.0%
This company
2023
2023
Equity ratio
-647.0%
This company
38.2%
Market median
Annual reports & filings
Annual report 2023
Filed via CVR / Virk · Period 2023-01-25 – 2023-12-31
View
PDF
More on Slingshot Biosciences Denmark ApS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
-794
Tax
-0
Net profit
-794
-1794% vs market
2023
2023
Return on equity
-79383100.0%
This company
18.4%
Market median
-431429991% vs market
2023
2023
Net profit margin (of gross profit)
-79383100.0%
This company
2023
2023
Asset turnover (of gross profit)
-0.39×
This company
2023
2023
Debt / equity
1.15×
This company
0.62×
Market median
-85% vs market
2023
2023
